Mirai: future breast cancer risk from mammograms
Mirai, trained on over 200,000 exams, was evaluated on hospital data from the United States, Sweden, and Taiwan. In a comparison of high-risk groups at Massachusetts General Hospital, it identified nearly twice as many future diagnoses as Tyrer-Cuzick; it does not demonstrate reduced mortality.
Technology: Deep learning on mammograms
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Mirai was validated on held-out test sets from MGH, Karolinska and Chang Gung, and identified nearly twice as many future diagnoses as Tyrer-Cuzick in high-risk groups.
- Still unknown: It does not use prior imaging and is still being validated in more diverse populations, and it does not show reduced mortality.
- AI role: Deep learning predicted future breast cancer risk from mammograms.
Evidence sources: https://news.mit.edu/2021/robust-artificial-intelligence-tools-predict-future-cancer-0128 · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A10.1126/scitranslmed.aba4373&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 320 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.